EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
1.8.98.2 | Idiopathic Pulmonary Fibrosis |
20718723 |
Cell-specific elevation of NRF2 and sulfiredoxin-1 as markers of oxidative stress in the lungs of idiopathic pulmonary fibrosis and non-specific interstitial pneumonia. |
causal interaction diagnostic usage unassigned |
2 2 0 |
1.8.98.2 | Lung Diseases, Interstitial |
20718723 |
Cell-specific elevation of NRF2 and sulfiredoxin-1 as markers of oxidative stress in the lungs of idiopathic pulmonary fibrosis and non-specific interstitial pneumonia. |
causal interaction diagnostic usage unassigned |
2 2 0 |
1.8.98.2 | Neoplasms |
30177848 |
Chemical proteomics reveals new targets of cysteine sulfinic acid reductase. |
unassigned |
0 |
1.8.98.2 | Chronic Periodontitis |
30044495 |
Comparative estimation of sulfiredoxin levels between chronic periodontitis and healthy patients - A case-control study. |
causal interaction diagnostic usage ongoing research unassigned |
4 4 3 0 |
1.8.98.2 | Periodontal Diseases |
30044495 |
Comparative estimation of sulfiredoxin levels between chronic periodontitis and healthy patients - A case-control study. |
causal interaction diagnostic usage ongoing research unassigned |
4 4 3 0 |
1.8.98.2 | Periodontitis |
30044495 |
Comparative estimation of sulfiredoxin levels between chronic periodontitis and healthy patients - A case-control study. |
causal interaction diagnostic usage ongoing research unassigned |
4 4 3 0 |
1.8.98.2 | Breast Neoplasms |
25833832 |
Correction: Genetic Polymorphisms and Protein Expression of NRF2 and Sulfiredoxin Predict Survival Outcomes in Breast Cancer. |
causal interaction diagnostic usage therapeutic application unassigned |
2 3 1 0 |
1.8.98.2 | Neoplasms |
27825965 |
Effective killing of cancer cells and regression of tumor growth by K27 targeting sulfiredoxin. |
unassigned |
0 |
1.8.98.2 | Neoplasms |
31394427 |
Elucidation of the inhibition mechanism of sulfiredoxin using molecular modeling and development of its inhibitors. |
therapeutic application unassigned |
2 0 |
1.8.98.2 | Melanoma |
31248223 |
Frugoside Induces Mitochondria-Mediated Apoptotic Cell Death through Inhibition of Sulfiredoxin Expression in Melanoma Cells. |
causal interaction ongoing research therapeutic application unassigned |
2 2 1 0 |